Saji M - Search Results

1

Akt: a potential target for thyroid cancer therapy.

Kada F, Saji M, Ringel MD. Kada F, et al. Among authors: saji m. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Sep;4(3):181-5. doi: 10.2174/1568008043339857. Curr Drug Targets Immune Endocr Metabol Disord. 2004. PMID: 15379721 Review.

2

Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells.

Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M. Ringel MD, et al. Among authors: saji m. J Clin Endocrinol Metab. 2002 May;87(5):2399. doi: 10.1210/jcem.87.5.8626. J Clin Endocrinol Metab. 2002. PMID: 11994395

3

Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells.

Ramljak D, Coticchia CM, Nishanian TG, Saji M, Ringel MD, Conzen SD, Dickson RB. Ramljak D, et al. Among authors: saji m. Exp Cell Res. 2003 Jul 15;287(2):397-410. doi: 10.1016/s0014-4827(03)00135-6. Exp Cell Res. 2003. PMID: 12837294

4

Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit.

Stabile E, Zhou YF, Saji M, Castagna M, Shou M, Kinnaird TD, Baffour R, Ringel MD, Epstein SE, Fuchs S. Stabile E, et al. Among authors: saji m. Circ Res. 2003 Nov 28;93(11):1059-65. doi: 10.1161/01.RES.0000105086.31909.1B. Epub 2003 Nov 6. Circ Res. 2003. PMID: 14605018

5

17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels.

Braga-Basaria M, Hardy E, Gottfried R, Burman KD, Saji M, Ringel MD. Braga-Basaria M, et al. Among authors: saji m. J Clin Endocrinol Metab. 2004 Jun;89(6):2982-8. doi: 10.1210/jc.2003-031767. J Clin Endocrinol Metab. 2004. PMID: 15181088

6

Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells.

Miyagi E, Braga-Basaria M, Hardy E, Vasko V, Burman KD, Jhiang S, Saji M, Ringel MD. Miyagi E, et al. Among authors: saji m. Mol Carcinog. 2004 Oct;41(2):98-107. doi: 10.1002/mc.20042. Mol Carcinog. 2004. PMID: 15378648

7

Overexpression and overactivation of Akt in thyroid carcinoma.

Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M. Ringel MD, et al. Among authors: saji m. Cancer Res. 2001 Aug 15;61(16):6105-11. Cancer Res. 2001. PMID: 11507060

8

Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.

Bauer AJ, Terrell R, Doniparthi NK, Patel A, Tuttle RM, Saji M, Ringel MD, Francis GL. Bauer AJ, et al. Among authors: saji m. Thyroid. 2002 Nov;12(11):953-61. doi: 10.1089/105072502320908286. Thyroid. 2002. PMID: 12490072

9

AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.

Kim CS, Vasko VV, Kato Y, Kruhlak M, Saji M, Cheng SY, Ringel MD. Kim CS, et al. Among authors: saji m. Endocrinology. 2005 Oct;146(10):4456-63. doi: 10.1210/en.2005-0172. Epub 2005 Jul 7. Endocrinology. 2005. PMID: 16002527

10

AKT in thyroid tumorigenesis and progression.

Shinohara M, Chung YJ, Saji M, Ringel MD. Shinohara M, et al. Among authors: saji m. Endocrinology. 2007 Mar;148(3):942-7. doi: 10.1210/en.2006-0937. Epub 2006 Aug 31. Endocrinology. 2007. PMID: 16946008 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters